Hatteras Venture Partners

Washington, District of Columbia
Founded:2000
Firm Location:Washington, District of Columbia • Durham, North Carolina • Asheville, North Carolina • Chapel Hill, North Carolina • Burlington, Vermont • Raleigh-Durham / Southeast US
Hatteras Venture Partners Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
n/a
$2.0M
($400K - $4.0M)
Investors in Durham (NC), Investors in Raleigh-Durham / Southeast US
+22
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in Burlington (VT)
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
n/a
$1.5M
($100K - $5.0M)
Investors in Asheville (NC)
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
+17
Photo of Don Rose, Venture Partner at Hatteras Venture Partners
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC)
n/a
$1.5M
($100K - $5.0M)
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
n/a
$1.5M
($100K - $5.0M)
Investors in Raleigh (NC), Investors in Durham (NC)
n/a
$1.5M
($100K - $5.0M)
Investors in St. Louis (MO), Investors in Washington (DC)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Midwest (Other Lists)
+10
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
+13
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1